The FDA called it “a historic day” as insulin and certain other biologic drugs transitioned to a different regulatory pathway. The 10-year transition built into the Biologics Price Competition and ...

Medicare beneficiaries will pay no more than $35 a month for insulin in 2023, while ongoing work will be needed to ensure that everyone in the United States with diabetes who needs insulin can afford ...

Please provide your email address to receive an email when new articles are posted on . The FDA on Monday announced the formal transition of insulin and certain other biologic drugs to a new ...

For the millions of people living with diabetes, insulin is a life-saving drug. Unlike many other medicines, though, insulin cannot be easily delivered by swallowing a pill — it needs to be injected ...

Drugs that target insulin pathways to slow or stop the growth of brain tumors are going in the right direction but appear to be on the wrong track, according to new research at Rice University.